[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100506255":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":28,"responsibleParty":40,"collaborators":43,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":10,"overallStatus":64,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Oslo University Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Women with gestational diabetes",null,"Any treatment. N=200.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control group","Gestational-age matched, euglycemic, normotensive pregnant women (n=150)",[16],{"name":17,"affiliation":18,"role":19},"Meryam Sugulle, PhD","Oslo University Hospital, Division of Gynaecology and Obstetrics, Ullevål","PRINCIPAL_INVESTIGATOR",[21,25],{"name":17,"role":22,"phone":23,"phoneExt":10,"email":24},"CONTACT","+47 22119800","UXSUME@ous-hf.no",{"name":26,"role":22,"phone":23,"phoneExt":10,"email":27},"Bendik Fiskå, M.D.","benfis@ous-hf.no",[29],{"facility":5,"status":10,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"Oslo","0407","Norway","NO",{"type":35,"coordinates":36},"Point",[37,38],10.74609,59.91273,{"lat":38,"lon":37},{"type":19,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Meryam Sugulle","Principal Investigator",[44],{"name":45,"class":6},"Norwegian SIDS and Stillbirth Society","100506255",false,"NCT05872009","Gestational Diabetes Mellitus: \"Placental-maternal Crosstalk and Future Health\"","The GaP Study: Gestational Diabetes Mellitus: \"Placental-maternal Crosstalk and Future Health","GaP","Inclusion Criteria:\n\n* Pregnant women \\>18 years with GDM giving birth at Oslo University hospital Ullevål.\n* Control group of gestational age matched euglycemic, normotensive pregnancies\n\nExclusion Criteria:\n\n* reduced fetal movements,\n* epilepsy\n* thyroidea dysfunction\n* hypertensive disorder of pregnancy\n* non-communicable disease\n* Communicable disease (such as HIV)\n* type 1 or type 2 diabetes.\n* not able to understand Norwegian or English.\n* under legal guardianship.","FEMALE","18 Years",{"count":56,"type":57},350,"ESTIMATED","OBSERVATIONAL","The GaP study is designed to close important knowledge gaps by:\n\n1. exploring placental health and cellular ageing in GDM and the association with neonatal outcome\n2. evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM",[61,62,63],"Gestational Diabetes","Cardiovascular Diseases","Placenta Diseases","NOT_YET_RECRUITING","2023-05-22",{"date":67,"type":68},"2023-05-23","ACTUAL",{"date":70,"type":57},"2023-06-01",{"date":72,"type":57},"2026-06",{"name":5,"class":6},1]